INSUBCONTINENT EXCLUSIVE:
NEW DELHI: After facing a rough patch in 2019, 10 multibagger stocks are off to a flying start in 2020
These stocks have jumped 14-43 per cent so far in 2020 after clocking negative returns for the previous year
For long-term investors, these stocks have delivered anywhere between 1,000 per cent and 22,300 per cent returns in last 10 years.
These
multibaggers included Ajanta Pharma
The stock fell 18 per cent in 2019 only to jump 43 per cent in 2020, taking its 10-year gains to a whopping 6,341 per cent.
La Opala RG is
up 32 per cent in 2020 so far after falling 33 per cent for the previous year
This stock jumped 4,500 per cent in last 10 years
Shares of Garware Technical Fibres, which were flat last year, are up 30 per cent this calendar
This stock has gained 23 per cent after rising 21 per cent in 2019.
Shares of Natco Pharma have gained 20.42 per cent year to date after
falling 13 per cent in 2019, Supreme Industries and Solar Industries have gained 20 per cent each after falling 2 per cent each in the
These stocks have gained 1,200-2,700 per cent in last 10 years.
BCCL - Non CopyrightOther multibaggers VIP Industries, Aegis Logistics and
Bombay Burmah Trading Corporation have gained 14-17 per cent in 2020 after a poor 2019
Analysts are positive on a few of these names.
Rough patch for most of these 10 stocks in fact lasted more than a year
In addition to 2019's fall, Ajanta Pharma was down 20 per cent in 2018 and 16 per cent in 2017
La Opala RG was down 28 per cent in 2018
Natco Pharma had fallen 29 per cent in 2018
Caplin was also down 39 per cent in 2018
led by superior execution in India/Asia/Africa branded generics segment that accounts for 67 per cent of sales and healthy traction in new
strong bargaining power with Chinese vendors for sourcing of luggage and efficient inventory management will lead to improvement in working
valuations.
Strong performance, Kotak Securities said, compelled the brokerage to continue to recommend BUY rating on Aegis Logistics last
look at the entire pharma space what we have been bullish has been on companies which have got significant business in India
If there is a significant growth happening in the domestic pharmaceutical industry, a stock like Torrent pharma or Natco Pharma can
Virus Impact12 Feb, 2020Coronavirus outbreak in China has hit supply chains across the world and India is no exception
Indian importers of raw materials too are facing problems as China factories remain shut for some time now
But the development has also brought some relief for domestic companies who competes with finished Chinese goods
Santosh Meena, Senior Analyst at TradingBells believes that electronic equipment, organic chemicals, fertilisers and plastics are top import
sectors which may benefit from fall China imports.Here are five likely beneficiaries of the reduced imports: Dixon Technologies | CMP: Rs
"Make in India" theme is the key reason for the stellar performance of Dixon Technologies
Synergy with marquee names like Samsung and Xiaomi is also a key factor for the vertical growth of the company
The cost of production is increasing in China resulting in companies moving from China to India and Dixon technologies is a major
beneficiary of this phenomenon
The company has a strong order book for FY20-21
A cut in corporate tax is also boosting the bottom-line of the company
PI Industries | CMP Rs 1,540 | 1-year target: Rs 1,92012 Feb, 2020PI Industries is leading players in the agrochemicals space which is
getting major benefits from falling imports from China of fertilizer and chemical products
PI Industries is ready for multi-year growth in the CSM segment because of its enhanced R-D and supply scarcity related issues in China
Recently, it has witnessed big product wins and a significant surge in the deal pipeline
The company is in the mode of capacity expansion as management sees decent growth opportunities in the future
Supreme Industries | CMP Rs 1,375 | 1-year target Rs 1,66012 Feb, 2020Plastic products are the major beneficiaries of falling crude oil
Recently Supreme Industries has witnessed decent margin expansion amid a slow down in volume
The future growth outlook is bright as management expects volume to pick-up, led by a revival in demand from packaging and plastic piping
The company witnessed strong demand from that scheme in Bihar and Uttar Pradesh
IOL Chemical - Pharmaceutical | CMP: Rs 193 | 1-year target: Rs 25512 Feb, 2020API and chemical business is shifting from China to India
after pollution control measures are taken by the Chinese government
A recent fall in imports from China due to Coronavirus will lead to further growth in revenue and margin for Indian companies where IOLCP is
a perfect play for both specialty chemical and API business
It has a profit growth of 34% CAGR for the last 5 years with a ROE of 36%
It has footprints in 56 countries and regularly supplying its high-quality products to major pharmaceutical players